Could things go from bad to worse for Neil Woodford?

Could more underperformance be ahead for Neil Woodford?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

This year has been one to forget for Neil Woodford. His investment decision-making ability has been questioned by a wide range of investors after a poor performance by his standards. His funds have generally underperformed their benchmarks, and this has led to his reputation suffering at least some damage.

Looking ahead, his fund performance may deliver strong returns in the long run. However, in the short run things could realistically go from bad to worse.

Big calls

One of the major decisions made by Neil Woodford this year has been to sell stakes in long-held companies such as GlaxoSmithKline and British American Tobacco. At the same time, he has purchased a large stake in Lloyds which makes it the fifth biggest holding in his UK Equity Income fund.

While in the long run Lloyds could perform well and deliver high returns, the reality is that the UK economy faces a highly challenging period. Brexit has caused confidence to fall, which has helped to move inflation higher. With consumer spending likely to come under pressure due to falling real disposable incomes, the economic outlook for the UK seems tough. This could hurt the performance of banking stocks such as Lloyds. With the bank operating almost exclusively in the UK, its share price could come under pressure.

Although Lloyds makes up just 3.1% of Neil Woodford’s UK Equity Income fund, his decision to make it one of his top holdings could be scrutinised by investors. Should the bank’s share price fall in the short run, it may be viewed as another ‘error’ by the star fund manager.

Likewise, if Brexit negotiations continue to move along at a slow pace and the pound continues to weaken as the prospect of a ‘no deal’ builds, international stocks such as GlaxoSmithKline and British American Tobacco may see their share prices rise in the short run. Having sold them recently, this could be seen as a further mistake by Woodford.

Long-term potential

Of course, he has been in a similar position before. During the dotcom bubble he was viewed as being out of touch with a new growth avenue. He sat out the bubble and endured criticism for doing so – until it burst and suddenly he was back in fashion once more. Therefore, a similar journey may be ahead this time around.

Certainly, his short-term performance has been disappointing. But the reality is that no investment style, strategy or fund manager can constantly stay ahead of their benchmark. Sometimes one strategy is successful for a period, then events happen and change the market. This can mean what was successful last year is no longer a worthwhile strategy – as was the case regarding the dotcom bubble and subsequent crash.

While things may get worse before they get better for Neil Woodford, in the long run he could be proved right in his decisions. With his reputation being somewhat less impressive than it once was, now could be the perfect time to buy his funds for the long term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares in GlaxoSmithKline, British American Tobacco and Lloyds. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

Just released: our top 3 small-cap stocks to consider buying in October [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Investing Articles

How I’d use an empty Stocks and Shares ISA to aim for a £1,000 monthly passive income

Here's how using a Stocks and Shares ISA really could help those of us who plan to invest for an…

Read more »

Investing Articles

This FTSE stock is up 20% and set for its best day ever! Time to buy?

This Fool takes a look at the half-year results from Burberry (LON:BRBY) to see if the struggling FTSE stock might…

Read more »

Investing Articles

This latest FTSE 100 dip could be an unmissable opportunity to pick up cut-price stocks

The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

As the WH Smith share price falls 4% on annual results, is it still worth considering?

WH Smith took a hit after this morning’s results left shareholders unimpressed. With the share price down 4%, Mark Hartley…

Read more »

Investing Articles

The Aviva share price just jumped 4.5% but still yields 7.02%! Time to buy?

A positive set of results has put fresh life into the Aviva share price. Harvey Jones says it offers bags…

Read more »

Investing Articles

Can a €500m buyback kickstart the Vodafone share price?

The Vodafone share price has been a loser for investors in recent years, and the dividend has been cut. We…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Growth Shares

3 mistakes I now avoid when choosing which growth stocks to buy

Jon Smith runs through some of the lessons he's learnt the hard way over the years about what to look…

Read more »